Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population

Pediatric Blood and Cancer

Volumn 52, Issue 1, 2009, Pages 102-107

  Hyatt, Sarah A ^a   Wang, Wei ^b   Kerlin, Bryce A ^b,c   O'Brien, Sarah H ^b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Pediatric; Type 1 von Willebrand disease

Indexed keywords

ABNORMAL LABORATORY RESULT; ADOLESCENT; ARTICLE; ATTENTION; BLEEDING; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CRITERION RELATED VALIDITY; DIAGNOSTIC VALUE; DYSTOCIA; FAMILY HISTORY; FEMALE; HEMOSTASIS; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; NORMAL VALUE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THROMBOSIS; VALIDITY; VON WILLEBRAND DISEASE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; FAMILY HEALTH; NEWBORN; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STANDARD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; LABORATORY TECHNIQUES AND PROCEDURES; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; VON WILLEBRAND DISEASE;

EID: 58149392261     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21755     Document Type: Article

References (14)

1. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J 1993;7:308-316.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-459.
3. Sadler JE. Von Willebrand disease type 1: A diagnosis in search of a disease. Blood 2003;101:2089-2093.
4. Nichols WC, Ginsburg D. von Willebrand disease. Medicine 1997;76:1-20.
5. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005;3:775-777.
6. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population-comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000;84:401-409.
7. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006;4:2103-2114.
8. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-1695.
9. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008;14:171-232.
10. Laffan M, Brown SA, Collins PW, et al. The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004;10:199-217.
11. Eikenboom J, Van Marion V, Putter H, et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006;4:774-782.
12. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007;109:145-154.
13. Di Paola J, Federici AB, Mannucci PM, et al. Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999;93:3578-3582.
14. Tosetto A, Rodeghiero F, Castaman G, et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: Results from a multicenter European Study (MCMDM-1VWD). J Thromb Haemost 2007;5:715-721.